Seoul [South Korea], March 9: LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global pharmaceutical and biotechnology industry event taking place in New York from March 23 to 26, to explore new partnership opportunities and strengthen its global presence in the
Mumbai (Maharashtra) [India], February 27: Avery Pharmaceuticals Pvt. Ltd. showcased its innovative Mouth Dissolving Strips and CDMO solutions at Vitafoods India 2026, held from February 11-13 at the Jio World Convention Centre in Mumbai. Over 500 visitors engaged with our booth, showcasing
Gurugram (Haryana) [India], February 23: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major.
New Delhi [India], February 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26.
Mumbai (Maharashtra) [India], February 6: Avery Pharmaceuticals Pvt. Ltd., a specialty pharmaceutical company and leading innovator in advanced oral drug delivery technologies, is pleased to announce its participation in Vitafoods India 2026, the country's premier nutraceutical and wellness
Health officials on Tuesday inspected and reviewed the suspected outbreak at the JNV campus located in Gurujanga village. Senior district-level officers, including Chief District Medical Officer (CDMO) Sanjay Roy and District Public Health Officer Dr Ranjan Mitra, visited the school to as
New Delhi [India], November 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26.
The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs, according to a report by Systematix Research
New Delhi [India], August 9: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter ended June 30, 2025. This quarter continued to display strong performance with healt
Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.
New Jersey [US]/ Ahmedabad (Gujarat) [India], June 3: Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as "Zydus) today announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to a
New Delhi [India], May 27: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter and fiscal year ending March 31, 2025. The fourth quarter marked a significant rebound